Their gain-of-function assays confirmed that up-regulation of miR-1224 displayed increased abilities of the invasion and growth of glioma cells by targeting CREB1 However, whether miR-1224 may display a similar in other tumors remains unclear. The gene discussed is CREB1; the disease is central nervous system cancer.